Compound and Pharmaceutical composition for the treatment of a disorder of the central nervous system related to or affected by the Histamine Receptor 3 and for the H3 Receptor Inhibition and Process for the preparation of the compound

摘要

Item 1: a formula compound (1)X is co, CH2 or SOM; y is NR6, nr6co, or SOP; m and P are 0 or 1 or 2 integers respectively; R1 and R2 are independent h or a group of selectively substituted tar or R1 and R2, which can be combined with atoms to form a ring composed of 4 to 7 selectively substituted members, including one or two extra heteroatoms selected from n or s; R3 is nr7r8 or arilo or heterosexual, and each group is an alternative, provided that when y is NR6 or SOP, R3 must be an arilo or heterosexual group,Or9 or a group of asphalt, beryllium, asphalt, cyclopentyl, cyclopentyl, cyclopentyl or isomerized substances, each of which is an alternative; R6 and R9 are independent h or a group of alternative asphalt respectively; R7 and R8 are combined with atoms to form a selective alternative ring system consisting of 9-A 11 ring system, consisting of two or three extra heteromorphic atoms selected from n or s, or stereoisomerized atoms produced by these atoms, or an acceptable medical salt produced by these atoms. These ones here.